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A novel apoptosis-specific protein (ASP) has recently been identified in the cytoplasm of
apoptotic mammalian cells. This paper investigates whether ASP is found in Xenopus thymus
tumor-derived lymphoid cell lines undergoing apoptosis and also in apoptotic, nontransformed
splenocytes. Cultured Xenopus tumor lymphoid cells induced to undergo, apoptosis by serum
deprivation or treatment with the calcium ionophore, ionomycin, displayed altered morphology
typical of apoptotic cells, as judged by flow cytometric light-scatter characteristics and by
fluorescence’ microscopy of acridine-orange-stained cells. Flow cytometry of permeabilized cells
and fluorescence microscopy of acetone-fixed cytospins revealed that apoptotic Xenopus tumor
cells, especially those displaying loss or condensation of DNA, displayed increased expression
of epitopes recognized by a rabbit polyclonal antibody against ASP. Flow cytometry confirmed
that ASP is also expressed in splenocytes induced to apoptose by culture in ionomycin or
following concanavalin A stimulation. No increased expression ofASP was seen when lymphoid
tumor cells or splenocytes were induced into necrosis by overdose with the antifungal agent
amphotericin B. Western blotting with antibody against ASP identified the emergence of several
protein bands in cell lysates from apoptotic, but not necrotic, Xenopus tumor cells. The new and
simple methodology for identifying apoptotic cells described here is likely to be of value to those
studying immune system development and associated programmed cell death in Xenopus.
Keywords: Apoptosis-specific protein (ASP) evolution, apoptosis detection by flow cytometry, lymphoid
tumor cells, Xenopus immune system
INTRODUCTION
Apoptosis plays a crucial role in the development,
physiology, and pathology of the immune system
(Gregory, 1995). During ontogeny, T and B lympho-
cytes that are autoreactive or nonfunctional, due to
inappropriate rearrangement of antigen-receptor gene
segments, die by apoptosis (Osborne, 1996). Cytolytic
lymphocytes (both T and NK cells) kill by inducing
apoptosis in their target cells (Berke, 1995), a
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mechanism that, unlike necrosis, prevents inflamma-
tion or spilling of cellular contents that might damage
or infect surrounding healthy cells. Inappropriate
apoptosis of lymphocytes may be triggered in some
pathologies, for example, AIDS (Duke, 1996).
In mammals, apoptosis can be characterized
morphologically by cell shrinkage, nuclear pycnosis,
chromatin condensation, and plasma membrane bleb-
bing, with rapid phagocytosis of apoptotic cells
(Martins and Earnshaw, 1997). A cascade of
molecular and biochemical events is also associated
with apoptosis (An and Knox, 1996; Nagata, 1997),
including the interaction between apoptosis-signaling
cell-surface TNF-receptor family members (such as
fas) and their ligands (e.g., fas ligand), subsequent
intracellular signaling by death factors such as the
caspase family of cysteine proteases, and the frag-
mentation and loss of DNA. Recently, a novel
"apoptosis-specific protein" (ASP) has been identified
in human Burkitt lymphoma cells and in adenovirus-
transformed human and rat embryo cells (Grand et al.,
1995). ASP is expressed when these cells are
triggered to apoptose by a variety of stimuli, including
serum deprivation and exposure to ionomycin. ASP
was identified using a rabbit polyclonal antibody
raised against a synthetic peptide of the human c-jun
protein, which cross reacts with ASP. Western
blotting revealed that the principal peptide (ASP)
detected by this antibody in apoptotic cells had a
molecular weight of 45-kD, rather than the 39-kD
bona fide c-jun protein. ASP is found in the
cytoplasm, whereas c-jun, a component of the acti-
vator protein (AP-1) transcription factor, is located
in the nucleus. Increased ASP expression in apoptotic
cells appears to be attributable to an increase in
translation of preexisting mRNA (Hammond et al.,
1998). ASP persists long after cell death and appears
to form part of a modified cytoskeleton perhaps
responsible for maintenance of membrane integrity in
apoptosing cells prior to their phagocytosis (Grand et
al., 1995).
Since evolutionary conservation of the molecular
basis of apoptosis is indicated from comparative
studies of programmed cell death from mammals
back to invertebrates such as nematodes (Martins and
Earnshaw, 1997), it might be expected that apoptosis
at the amphibian level of evolution can be identified
by probes used for mammalian apoptosis. In this
paper, we investigate whether the anti-ASP antibody
used by Grand et al. (1995) can identify conserved
apoptosis-specific proteins in Xenopus, whose
immune system development is being explored in
depth (Du Pasquier et al., 1996; Horton et al., 1996a).
Our studies center on Xenopus thymus tumor-derived
lymphoid-cell lines B3B7 and 15/0 (Du Pasquier and
Robert, 1992; Robert et al., 1994), since novel
apoptotic markers for these tumor cells, being used as
targets for Xenopus cytolytic lymphocytes (for both
NK-like cells [Horton et al., 1996b], and T cells
[Horton et al, 1997a, 1997b]) would be of particular
value. The applicability of our findings to non-
transformed Xenopus cells is also briefly addressed,
by monitoring ASP in apoptotic splenic lympho-
cytes.
RESULTS
Experiments on lymphoid tumor cells were carried
out at room temperature (18-20C), and those on
splenocytes at 27C, as explained in the Materials and
Methods section.
Serum Deprivation Induces Apoptosis and ASP
Staining
B3B7 cells were kept for up to 336 hr (14 days) in
medium without subculture, in order to investigate the
effects of serum deprivation. Samples were periodi-
cally removed for flow cytometric and fluorescence
microscopic analysis. "Viable" cell concentration
assessed by microscopy (trypan blue exclusion)
initially increased from 2-3 105/ml at time of
seeding to 1-2 106/ml by 168 hr; by 336 hr, viable
cell numbers had diminished as dead cells and cell
debris became increasingly evident.
Samples were analyzed by flow cytometry for
alterations in cell size (FS) and granularity (SS).
Figure 1 shows that at the time of seeding, very few
B3B7 cells were gated as apoptotic, whereas by 336 hrAPOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 335
of culture, around 50% cells displayed reduced FS
signal but increased SS signal, features that in
mammals are indicative of apoptosis (Milner et al.,
1995).
Aliquots were also taken for fluorescence micro-
scopic analysis of either acetone-fixed cytospins
stained with anti-ASP (Figure 2E) or unfixed cells
stained with acridine orange (Figures 2A to 2D).
Replicate experiments revealed <5%. ASP-expressing
(ASP+) cells at the start of culture; by 168 hr, ASP
cells still represented <10%, but this figure con-
sistently rose to around 40% by 336 hr of culture
under serum-deprivation conditions. The ASP anti-
body stains a cytoplasmic epitope within the B3B7
cells (Figure 2E). Counterstaining of cytospins with
the DNA-binding fluorochrome propidium iodide (PI)
revealed that all ASP cells possessed either pycnotic
nuclei or loss of nuclear material; conversely, all the
cells with pycnotic nuclei (i.e., with classical morpho-
logic apoptotic criteria [Kerr et al., 1972]) were ASP+.
Moreover, the percentage of ASP cells recorded in
cytospins was directly comparable to the proportion
of unfixed cells scored as apoptotic on the basis of
acridine-orange staining (data not shown).
Comparison of ASP Staining Following
lonomycin-lnduced Apoptosis and Amphotericin-
Induced Necrosis
B3B7 cells were either cultured in medium containing
10 #g/ml ionomycin or 50 /g/ml amphotericin B.
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FIGURE Induction of apoptosis through serum deprivation. The series of representative flow cytometer histograms show changes in
forward scatter (FS) and side scatter (SS) of B3B7 Xenopus tumor cells (cultured in 10 ml tumor medium with no medium change) sampled
at 7 days (168 hr), 10 days, and at 14 days (336 hr). With time after seeding (0 hr), the events recorded shift from region A ("viable" cells)
to region D ("apoptotic" cells), as cells come to display reduced FS signal and increased SS signal. Ten thousand events were recorded per
histogram.APOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 337
with saponin to allow cytoplasmic staining. The
percentage of dead cells with leaky cell membranes
was also estimated by flow cytometric analysis of PI
stained, nonsaponin-treated samples (see Figure 3).
lonomycin Treatment (Figure 3A)
Fluorescence microscopic analysis of cytospins
revealed a sharp increase in ASP-expressing cells
between 24 hr (<5%) and 72 hr (approaching 20%)
following calcium ionophore treatment, the level of
ASP then appearing to plateau between 72 and 168 hr.
ASP cytospun cells, which were counterstained with
A Ionomycin-treated
+51
BASP+ (flw cytmetry)
E 40 epi (flowcytometry)
0 hrs 24 hrs 72 hrs 168 hrs
Length of incubation
B Amphotericin-treated
806070
o
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FIGURE 3 Graphs to show proportions of ASP and PI B3B7
cells at various times after culture with either (A) ionomycin (10
/g/ml) or (B) with 50 /xg/ml amphotericin B. The percentage of
ASP cells was measured by binding with rabbit anti-ASP primary
antibody and visualized by FITC-conjugated anti-rabbit Ig anti-
body, cells having been either transferred to slides and acetone-
fixed (for fluorescence microscopy) or unfixed suspensions sapo-
nin-treated (for flow cytometry). The percentage of dead cells (PI+)
with leaky plasma membranes was also estimated by flow
cytometry using nonsaponin-treated, unfixed cells. The fluores-
cence microscopy data were obtained by counting>500 cells from
at least 10 fields of coded cytospins. Flow cytometric data were
based on 10,000 events. Data are representative of three separate
experiments performed.
PI, consistently displayed pycnotic nuclei typical of
apoptosing cells. Flow cytometry of saponin-treated
cells revealed higher levels of ASP staining compared
to the cytospin data, but showed the same trend in
ASP expression. Thus, about 20% ASP cells were
recorded by cytometry when cultures were seeded and
again at 24 hr following ionomycin treatment,
whereas the level of ASP cells plateaued at around
50% from 72 to 168 hr. Since PI staining of
nonsaponin-treated tumor cells indicated a rapid rise
in cells with leaky plasma membranes only after 72 hr
of ionomycin treatment (from <20% to around 50% at
168 hr incubation), it is evident that the high ASP
level recorded (with the cytometer) at 72 hr precedes
loss of cell-membrane integrity. Lack of correlation
between cell-membrane leakiness and ASP staining is
als0 indicated by dual staining of nonpermeabilized
tumor cells with PI and with the ASP antibody, where
the PI population always contained both ASP and
ASP- cells (data not shown).
Amphotericin B Treatment (Figure 3B)
When used at a dose 20-fold higher than is effective
as a fungicide, amphotericin appears to induce
necrosis of tumor cells, since >50% of cells are dead
(PI+) within 72 hr of treatment and around 70%
display leaky cell membranes by 168 hr. Fluorescence
microscopy of cytospins revealed no increase in
proportion of ASP-containing cells over the 7-day
culture period and few cells with pycnotic nuclei (data
not shown). This lack of ASP staining following
amphotericin treatment was confirmed by flow cyto-
metry of saponin-treated cells; indeed, a lower
percentage of amphotericin-treated cells expressed
ASP than at the start of culture. This was probably
because no further apoptoses were induced and initial
ASP-containing cells were lost.
ASP Detection by Flow Cytometry
B3B7 Tumor Cells (Figure 4).
Flow cytometric traces highlight changes in ASP
staining patterns of B3B7 cells cultured without
medium change over a 7-day period. Cells were338 J. HORTON et al.
saponin-treated prior to staining with ASP antibody
and the percentages of ASP cells shown determined
by positive analysis. Such analysis sets markers to
exclude 98% cells stained with normal rabbit serum
(NRS). Permeabilization tended to result in consider-
able nonspecific binding of rabbit serum (both anti-
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FIGURE 4 Representative flow cytometric traces comparing the percentages of ASP B3Bv cells in samples taken at 24, 72, and 168 hr
after seeding to culture flasks. The thymus tumor cells were cultured either in tumor medium alone (serum-deprivation control) or in 10/xg/
ml of ionomycin (to induce apoptosis) or 50 keg/ml of amphotericin B (to induce necrosis). Cells were permeabilized with saponin prior to
staining with rabbit anti-ASP. The markers are set to exclude from positive analyses 98% of the cells stained with irrelevant primary antibody
(normal rabbit serum).APOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 339
ASP and NRS), which caused a shift of both the ASP
and ASP- peaks to higher fluorescence intensities
(see Figure 4). Cells cultured in medium alone and
those treated with 10 /xg/ml ionomycin displayed
distinct peaks of ASP-specific fluorescence, ion-
omycin inducing a more rapid effect than serum
deprivation alone. Cells induced to necrose by 50
ml amphotericin B failed to show elevated ASP
staining.
Splenocytes (Figure 5 and Figure 6).
omycin or amphotericin. Splenocytes cultured in
medium alone, then permeabilized with saponin prior
to staining with anti-ASP antibody, displayed 20%
ASP cells, whereas 35% were ASP after ionomycin
treatment. Amphotericin-induced necrotic cells
remained ASP-. Figure 6 reveals that after 7 days
culture in medium, 35% splenocytes were now ASP+,
whereas 70% of those cultured in Con A had become
ASP+. Extensive apoptosis in Con A-treated cultures
was also indicated by light-scatter analysis of non-
permeabilized cells (data not shown).
Splenocytes were also assessed by flow cytometry for
emergence of ASP during apoptosis. Figure 5 shows
the outcome of 72 hr in vitro culture of splenocytes in
medium alone or in medium containing either ion-
NRS Anti-ASP
2% 20%
35%
4%
FIGURE 5 Representative flow cytometric traces comparing the
percentages of ASP splenocytes following culture for 72 hr in
either medium, 1/xg/ml of ionomycin or 50/xg/ml of amphotericin
B. Cells were permeabilized with saponin prior to staining with
rabbit anti-ASP or nonimmune rabbit serum (NRS). The markers
are set to exclude from positive analysis 98% of the cells stained
with NRS.
Correlation ofASP Staining with Cells Displaying
DNA Loss (Figure 7)
Although the ploidy of B3B7 cells is somewhat
unstable (Du Pasquier et al., 1995), those that appear
to have either condensed DNA (with associated poor
intercalation of PI) or lost DNA (typical of apoptotic
cells, see Milner et al., 1995) can be identified from
flow cytometry of PI-stained, saponin-treated cells
(Figure 7) This figure shows that by 120 hr,
ionomycin treatment has induced a significant
increase (compared with medium controls) in cells
containing "sub-Gl" level of DNA. By backgating on
PI-stained cells, it can be seen that those with sub-G1
content of DNA are predominantly ASP (77% of
medium-cultured cells and 90% of ionomycin-treated
cells). In contrast, those cells cultured in medium for
120 hr that had normal (G1) content ofDNA (located
in region A) contain only a very low percentage
(--5%) that are ASP+. Interestingly, the relatively few
ionomycin-treated cells still in region A now contain
a high proportion (69%) that are ASP-positive; these
could represent apoptotic cells in G2M or S phase,
which have lost DNA and now appear in the G1
region, since this phenomenon has been seen pre-
viously with Burkitt lymphoma cells (Milner et al.,
1995).
Western Blotting
Figure 8A illustrates the outcome of serum depriva-
tion over a 336-hr period on 15/0 cells. Apoptosis
levels measured by analysis of light scatter reveal a
rather high (20%) level of apoptotic 15/0 cells at the340 J. HORTON et al.
time of seeding, and then a gradual increase in
apoptotic levels from 120 hr onwards. Western
blotting of lysates from these cells at the time of
seeding showed no apparent reactivity of anti-ASP,
but by 120 hr following seeding, a prominent 66-kD
band was recognized. By 336 hr of serum deprivation,
the 66-kD band was particularly noticeable and
additional bands (including one at 45-kD) were now
evident.
Western blots of lysates obtained from B3B7 cells at
various time points during culture in either serum-
deprived conditions or following treatment with
ionomycin, together with apoptotic levels, are shown
in Figure 8B. Consideration of the Western blots
allows a number of interesting observations to be
made. As with the 15/0 cells, a major band at 66-kD
appears in B3B7 cells induced to apoptose by either
serum deprivation or ionomycin treatment. Additional
bands are induced by both treatments, with molecular
weights of approximately 100, 50, 45, and 40-kD. The
induced 45-kD band appears to be only a minor
component in these particular apoptotic BB7 cells. A
35-kD band is present at low levels even in BB7 cells
displaying minimal apoptosis, but this band appears to
become more intense as apoptotic levels increase.
Compared with serum deprivation, ionomycin
induces a more rapid emergence of protein bands
identified by the ASP antibody. However, by late
times of culture, when light-scatter characteristics
indicate high numbers of apoptotic cells, similar
levels and sizes of ASP proteins are detected in
Westerns of both serum-deprived and ionomycin-
treated samples, findings that are in agreement with
the flow cytometric data shown in Figure 4.
Figure 9 compares Western blots of lysates taken
from recently seeded BB7 cells (lane 1): those treated
for 7 days with ionomycin (to induce extensive
apoptosis; (lane 2) and those induced to necrose
Medium 168h
35%
Con A 168h
70%
IIIIII III(
Anti-ASP
FIGURE 6 Representative flow cytometric traces comparing the percentages of ASP splenocytes following culture for 168 hr in medium
or /xg/ml of Con A. Cells were permeabilized prior to staining with anti-ASP. Markers were set as in Figure 5.APOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 341
following 24-hr treatment in amphotericin (lane 3).
(At the time cell lysates were prepared, only 4% of
recently seeded lymphocytes were recorded as apop-
totic by light-scatter analysis [i.e. in zone D of Figure
1], whereas 52% of the 7-day ionomycin-cultured
cells had apoptotic light-scatter profiles. Ninety-six
percent of the amphotericin-treated (necrotic) cells
displayed reduced forward light scatter, but no
increase in side scatter.) The Westerns illustrate that
ionomycin induces the appearance of several protein
bands detected by the rabbit anti-ASP antibody, but
not with nonimmune rabbit serum. In contrast,
necrotic B3Bv cells fail to display any increase in ASP
proteins over the level found in the viable cultures. As
in previous experiments, major bands at 66 and 45-kD
were detected with anti-ASP. Interestingly, the 45-kD
band was more highly expressed than the 66-kD one,
which mirrors the pattern found in human Burkitt
lymphoma cells. It remains to be determined why the
relative intensities of the 66- and 45-kD bands in
apoptotic B3B7 cells vary between experiments.
The reliability of ASP for monitoring apoptotic
levels in B3B7 cells was confirmed by use of the
TUNEL assay, which identifies fragmented DNA in
cell smears. Thus, recently seeded lymphoid tumor
cells were only 1% TUNEL+, in contrast to 64%
TUNEL cells after 7-day ionomycin treatment. Just
9% amphotericin-treated cells were TUNEL+.
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FIGURE 7 Representative flow cytometric analysis revealing association of ASP staining with cells displaying condensation or loss of
DNA. B3B7 cells were taken for FACS analysis 120 hr after seeding to flasks and culture in either medium (top row of histograms) or 10
#g/ml of ionomycin (bottom row of histograms). Cells were permeabilized with saponin prior to staining for presence of ASP and for DNA
content. The histograms at the left show propidium iodide (PI)--staining patterns, which reflect the different content of DNA in cells at
various phases of cell cycle: Region A mainly corresponds to cells in the G1 phase, region B to cells that have "sub-Gl" DNA content, region
C to cells in S phase or G2/M. Ionomycin treatment results in a significantly higher proportion of cells with sub-G DNA content, indicative
of increased apoptosis. Histograms at the center and right show percentages of ASP cells from regions B and A, respectively, of PI traces.
For medium-cultured cells, correlation between positive ASP staining (77%) and DNA loss/condensation (cells gated from region B) and
the converse lack of ASP staining (5%) in cells from gate A is clearly evident. Although 90% ionomycin-treated cells from sub-G1 region
B are ASP+, some 69% from region A are also ASP+.342 J. HORTON et al.
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FIGURE 8 Western blots of 15/0 (A) and B3B7 (B) lymphoid tumor cells showing appearance of protein bands identified by anti-ASP
antibody in lysates from cells following either serum deprivation (Co-C336 hours following seeding to culture medium) or ionomycin
treatment (I48-I192 hours following treatment with /xg/ml ionomycin). Levels of apoptotic cells (measured by light-scatter analysis, as
illustrated in Figure 1) in these same cultures are also shown. Burkitt lymphoma cells are the mammalian ASP control in the Westerns, the
main ASP band having a molecular weight of 45 kD. The data are representative of duplicate experiments.APOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 343
DISCUSSION
DNA loss/ fragmentation has been employed to
monitor mitogen-driven apoptosis of lymphocytes in
Xenopus (Grant et al., 1995), to investigate the
increased level of T-lymphocyte apoptosis occurring
at metamorphosis (Ruben et al., 1994; Barker et al.,
1997) and to study immune-mediated tail loss in this
amphibian (Izutsu et al., 1996). The experiments
presented here, while revealing that DNA loss can be
A B
1 2 3 1 2 3
66kDa
FIGURE 9 Western blots of viable (recently seeded) B3B lymphoid tumor cells (lane 1), in comparison with apoptotic lymphoid tumor
cells (168 hr after /xg/ml ionomycin treatment, lane 2) and necrotic tumor cells (24 hr after 50/xg/ml amphotericin B. lane 3). Levels of
apoptotic cells (monitored by TUNEL assay) in these same three cultures were 1, 64, and 9%, respectively. (A) Rabbit anti-ASP was used
to identify ASP protein bands in lysates from the three cell populations. (B) The same fractionated proteins were here incubated with control,
non-immune rabbit serum; lanes as in 9(A).344 J. HORTON et al.
used as a marker of ionomycin-induced apoptosis for
Xenopus tumor cells, introduce a novel assay for
monitoring programmed cell death in this amphibian.
Specifically, we show that a polyclonal antibody
raised against a synthetic peptide of human c-jun,
known to detect ASP in apoptosing mammalian cells
(Grand et al., 1995), is able to identify Xenopus
lymphoid tumor cells and nontransformed spleno-
cytes undergoing apoptosis. ASP expression in Xeno-
pus lymphoid cells and splenocytes can be induced by
serum deprivation, but more effectively by incubation
with ionomycin; Con A can also induce ASP
expression in splenocytes. Cells induced to necrose by
the membrane-disrupting fungicide, amphotericin B,
failed to become ASP This finding emphasizes that
apoptosis and necrosis are completely separate death
pathways in Xenopus, as in humans.
For immunostaining of ASP to constitute a valua-
ble and rapid method for detecting apoptosis in
Xenopus, it should be applicable not only to fluores-
cence microscopic analysis of cell smears, but also to
flow cytometric analysis of cell suspensions.
Although this would appear to be the case, the reasons
why a significantly higher proportion of lymphoid
tumor cells were identified as ASP-positive by flow
cytometry than by fluorescence microscopy needs to
be resolved. Undoubtedly, the cytometer is more
sensitive at fluorescence detection than microscopy
and therefore possibly our cytometric analyses detect
lower intensities of ASP expression, such as might be
found in early apoptotic cells, which have yet to show
pycnotic nuclei. On the other hand, the "ASP" signal
seen in flow cytometry may be due to immuno-
detection both of genuine ASP and also of c-jun,
against which the anti-ASP antibody was raised. The
c-jun is localized in the nucleus and it is known that
it can be upregulated at the onset of apoptosis
(Collotta et al., 1992). However, we should point out
that no nuclear staining was detected in fluorescence
microscopic examination of cytospins of apoptotic
B3B7 cells.
It seems likely, in view of its cytoplasmic distribu-
tion, and correlation both with cells displaying
pycnotic nuclei and those with reduced DNA content,
that a major epitope in Xenopus cells recognized by
the ASP antibody is in fact ASP, which has been
sufficiently conserved between mammals and
amphibians. Our finding that the ASP antibody
recognizes several protein bands in Western blots of
apoptosing B3B7 and 15/0 Xenopus lymphoid tumor
cells is similar to the situation in apoptosing mam-
malian cells, where in addition to the major ASP
protein of 45-kD molecular weight, several other
components of between 20 and 150-kD have been
observed, suggesting a family of apoptosis-specific
proteins (Grand et al., 1995). Recently, cDNA
encoding the 32-kD component of this protein family
has been cloned from a human expression library and
this has significant homology to a yeast gene essential
for autophagy (Hammond et al., 1998). As yet, it is
unknown whether this gene encodes all ASP species.
It is conceivable that the variety of ASP proteins seen
in Westerns arise through posttranslational modifica-
tion of the 32-kD ASP. Western blots of apoptosing
Xenopus tumor cells, while indicating emergence of a
protein of 45-kD, reveal this is not always the major
induced band recognized by the ASP antibody.
Molecular studies are now required to determine the
nature of the various bands seen in apoptosing
Xenopus lymphoid tumor cells.
In summary, we have been able to detect emer-
gence of protein(s) in apoptotic but not necrotic
Xenopus thymus tumor cell lines and also in apoptotic
splenocytes, by use of an anti-c-jun polyclonal
antibody, which has been previously employed to
identify ASP in apoptosing mammalian cells. Detec-
tion of apoptotic proteins in Xenopus has been
possible not only by fluorescence microscopy of fixed
cell smears and by Western blot analysis of cell
lysates, but also by flow cytometric analysis of
permeabilized unfixed cell suspensions, the latter in
itself being a novel finding (contrast methodologies
used by Grand et al., 1995). This new and simple
methodology for identifying apoptotic Xenopus cells
should expedite studies on the development of the
Xenopus immune system, such as those investigating
the extensive restructuring of immune system cells at
metamorphosis (Flajnik et al., 1987; Rollins-Smith
and Cohen, 1996) and others (Horton et al., 1996b,APOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 345
1997a, 1997b( studying the mechanism of tumor-cell
cytotoxicity induced by cytolytic lymphocytes.
MATERIALS AND METHODS
Gibco). (Additional experiments to the ones reported
here on apoptosis induction in B3B7 cells were also
carried out at 27C; although kinetics of events were
more rapid, these studies yielded comparable data.)
Tumor-Cell Maintenance and Induction of
Apoptosis or Necrosis
The tumor-cell lines B3B7 and 15/0 were a generous
gift from Dr. Louis Du Pasquier. B3B7 cells are
derived from a thymus tumor found in partially
inbred, MHC homozygous Xenopus laevis family ff
(Robert et al., 1994), whereas the 15/0 cell line is
derived from a thymus tumor from an LG15 (X.
laevis/X, gilli clone 15) clonal Xenopus. In our
laboratory, these lymphoid tumor-cell lines are main-
tained in the Xenopus tumor-cell medium at 27C,
subculturing when cell numbers approach 2.0
106/ml to maintain a high proportion of viable cells,
new flasks being seeded at approx 2 105/ml. The
tumor-cell medium has the following composition:
400 ml serum-free medium (as given below) diluted
to amphibian strength with 120 ml triple-distilled
water and supplemented with 40 ml supernatant from
the A6 amphibian kidney-cell line (Rafferty, 1969),
10 ml decomplemented fetal-calf serum (FCS from
Advanced Protein Products), and 200/zg/ml kanamy-
cin (Gibco). The 15/0 cells were additionally supple-
mented with 0.25% Xenopus serum. Serum-free
medium comprises 500 ml Iscove’s medium, 5 ml
100 nonessential amino acids, 50/xg/ml penicillin/
streptomycin (all from Gibco), 5 /zg/ml insulin
(Sigma), 50 mmol mercaptoethanol (Sigma), and
1.5% Primatone (Roche).
B3B7 or 15/0 cells were seeded to culture flasks at
2-3 106 cells in 10 ml tumor medium, and then
incubated at 18-20C since our preliminary observa-
tions revealed that cells cultured at this lower
temperature were more robust (than those cultured at
27C) for the purpose of cytospin preparation.
Apoptosis was induced either by serum deprivation,
where cells were kept for up to 14 days without
subculture, or by treatment with either or 10/zg/ml
ionomycin (Sigma). Necrosis was induced by addition
of 50 /xg/ml amphotericin B ("Fungizone" from
Splenocyte Apoptosis/Necrosis
Splenocyte suspensions (2 106/ml) from outbred X.
laevis were depleted of erythrocytes by Ficoll density-
gradient centrifugation. One milliliter aliquots in
tumor medium (see earlier) were added to 24-well
plates and cultured at 27C. Apoptosis was induced
by 72-hr treatment with 1.0/zg/ml ionomycin, and by
7-day culture in either medium alone (serum depriva-
tion) or in the presence of the T-cell mitogen
concanavalin A (1.0/zg/ml). Necrosis was induced by
3-day treatment with 50/zg/ml amphotericin B.
Anti-ASP Antibodies
Two anti-ASP antibodies have been used in our
experiments with comparable results. Both are rabbit
polyclonal antibodies raised against synthetic pep-
tides of c-jun proteins. Initial studies were with Ab-2
(anti-c-jun/AP-1) antibody (Oncogene Research
Products), raised against a synthetic peptide corre-
sponding to residues 73-87 of human c-jun. Since
recent batches of this antibody have failed to stain
both human and Xenopus ASP, we are therefore
currently using the SC-45 (c-jun/AP-l[N]) antibody
(Santa Cruz Biotechnology), raised against a similar
peptide of mouse c-jun. This reproducibly stains
human and Xenopus ASP. (A number of other
commercially available antibodies to c-jun have been
tested that fail to cross-react with mammalian ASP
[Grand et al., 1995]).
Fluorescence Microscopy of Tumor Cells
ASP Staining.
Tumor cells were transferred to microscope slides by
use of a Cytospin (Shandon). 1 105 cells in 100/zl
40%-FCS-supplemented amphibian PBS (APBS)
were loaded into cuvettes and transferred to APBS
(40%-FCS)-prewetted slides by centrifugation at 600346 J. HORTON et al.
rpm for 5 min. After air drying, slides were fixed in
acetone for 10 min, then stored at -80C until
needed. Slides were transferred to a moist chamber,
blocked with APBS + 1% BSA, then stained for 45
min with 50 /xl anti-ASP antibody (1:100). Normal
rabbit serum provided a negative staining control (not
shown). After washing in 0.1% BSA-supplemented
APBS, primary antibody binding was visualized by
staining for 30 min with 50 /xl FITC-conjugated
polyclonal goat anti-rabbit-Ig antibody (1:160)
(Sigma), adsorbed prior to use with 1:20 dilution of
Xenopus serum. Slides were again washed well and
then counterstained for 2 min with 40/xg/ml propi-
dium iodide (PI) in APBS. Washed slides were finally
mounted with coverslips using a glycerol-based
mountant.
Acridine-Orange Staining.
Acridine orange (Sigma) at 10/xg/ml in APBS was
added to a pellet of 2 105 APBS (0.1% BSA)-
washed tumor cells. After gentle resuspension, 10/xl
cell suspension was pipetted onto a slide and the
sample immediately examined by fluorescence
microscopy.
Microscopy.
Coded slides were examined with a Nikon Optiphot
fluorescence microscope with incident light illumina-
tion, using a FITC-filter set. At least 500 cells in
minimally 10 fields were counted on duplicate slides,
to obtain large enough sample sizes. The number of
ASP cells or cells with pycnotic nuclei (latter
identified by staining with PI or acridine orange)
counted in each field was expressed as a proportion of
the total number of cells in that field, and the mean
proportion in all the fields was calculated.
Flow Cytometry
B3B7 lymphoid-cell lines or splenocytes were washed
twice in FACS medium (APBS, containing 0.1%
BSA and 0.1% NAN3). Some cells were then perme-
abilized by 30-sec treatment of 1-2 106 pelleted
cells with 100 /xl 0.1% saponin (Sigma) in FACS
medium, prior to addition of excess FACS medium.
Following two washes, the permeabilized cells and
others left untreated were aliquoted into a 96-well
plate (2 105 cells/well), then incubated with either
1:100 rabbit anti-ASP (see earlier) or with 1:100
normal rabbit serum (NRS) to provide control stain-
ing levels. Following another two washes, cells were
stained in 1:160 FITC-conjugated goat anti-rabbit
secondary antibody (see earlier) and again washed.
Immediately prior to analysis in the flow cytometer,
antibody-stained cells (1 106/ml) were counter-
stained with PI (40 /xg/ml). Markers were set to
exclude 98% of cells stained with normal rabbit
serum from positive analysis of ASP staining levels.
Ten thousand tumor cells per sample were analyzed
On a Coulter XL flow cytometer.
Nonpermeabilized Cells.
Nonpermeabilized cells were used both for assessing
apoptosis as judged by alteration in forward/side-
scatter properties (see Milner et al., 1995) and also for
monitoring the proportion of cells with "naturally
occurring" leaky plasma membranes, as revealed by
propidium iodide (PI) entry.
Permeabilization.
Permeabilization allows intracellular staining by anti-
ASP of all ASP cells, including many that before
saponin treatment would not have stained because
they had intact plasma membranes. Permeabilization
also enables PI to monitor total DNA and hence
identify cells in various phases of cell cycle, including
apoptotic cells, many of which should display reduced
DNA levels.
Western Blotting of Tumor-Cell Lysates
Cells were harvested, washed once in PBS, pelleted
by centrifugation, and the pellets stored at -20C.
Thawed pellets were lysed in 9 M urea, 50 mM Tris-
HCL, pH 7.4, 0.15 M /3-mercaptoethanol, then
sonicated. Aliquots containing equal amounts ofAPOPTOSIS-SPECIFIC PROTEIN IN XENOPUS 347
protein (50/zg) were subjected to 12% SDS-PAGE.
The fractionated proteins were transferred to nitro-
cellulose membranes that were incubated with either
nonimmune rabbit serum (diluted 1:200) as control
reagent, or rabbit anti-ASP antibody diluted 1:200,
and then with anti-rabbit horseradish peroxidase-
conjugated antibody (Dako). Target proteins were
visualized using ECL reagent (Amersham Inter-
national)
TUNEL Assay on Tumor Cells
Samples of B3B7 cells to be monitored for ASP
proteins by Western blotting were transferred to slides
and assessed for apoptosis using the TUNEL (TdT-
mediated dUTP Nick-End Labeling) assay, to end-
label fragmented DNA found in apoptotic cells. A
Boehringer "in situ cell death detection kit" was used
in this assay. The manufacturer’s instructions were
followed exactly, except that samples were incubated
for just 15 min at 37C.
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